These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7994047)

  • 1. Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia.
    Ellison DJ; Sharpe RW; Robbins BA; Spinosa JC; Leopard JD; Saven A; Piro LD
    Blood; 1994 Dec; 84(12):4310-5. PubMed ID: 7994047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia.
    Hakimian D; Tallman MS; Kiley C; Peterson L
    Blood; 1993 Sep; 82(6):1798-802. PubMed ID: 7691237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of complete remission after 2-chlorodeoxyadenosine for hairy cell leukemia: utility of marrow immunostaining and measurement of splenic index.
    Tallman MS; Hakimian D; Dyrda S; Kiley C; Nemcek A; Peterson L
    Leuk Lymphoma; 1994; 14 Suppl 1():133-8. PubMed ID: 7529609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
    Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical detection and quantification of minimal residual disease using DBA.44 antibodies in trephination biopsies of hairy cell leukemia].
    Dĕdic K; Zák P
    Cesk Patol; 2003 Oct; 39(4):175-7. PubMed ID: 14663929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
    Zák P; Chrobák L; Dĕdic K; Podzimek K
    Vnitr Lek; 2000 Oct; 46(10):697-703. PubMed ID: 11344629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New rearrangement pattern after treatment of hairy-cell leukemia with 2-chlorodeoxyadenosine.
    Schirmer M; Haun M; Grünewald K; Geisen F; Hilbe W; Thaler J; Konwalinka G
    Acta Haematol; 2000; 103(2):109-11. PubMed ID: 10838455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Wheaton S; Tallman MS; Hakimian D; Peterson L
    Blood; 1996 Feb; 87(4):1556-60. PubMed ID: 8608247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.
    Tallman MS; Hakimian D; Kopecky KJ; Wheaton S; Wollins E; Foucar K; Cassileth PA; Habermann T; Grever M; Rowe JM; Peterson LC
    Clin Cancer Res; 1999 Jul; 5(7):1665-70. PubMed ID: 10430066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
    Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
    Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapy.
    Gillis S; Amir G; Bennett M; Polliack A
    Eur J Haematol; 2001 Jan; 66(1):7-10. PubMed ID: 11168501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I; Zdziarska B; Krygier-Stojałowska A
    Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Scripps Clinic experience with 2-chlorodeoxyadenosine in the treatment of hairy cell leukemia.
    Piro LD; Ellison DJ; Saven A
    Leuk Lymphoma; 1994; 14 Suppl 1():121-5. PubMed ID: 7820043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential predictive patterns of minimal residual disease detected by immunohistochemistry on bone marrow biopsy specimens during a long-term follow-up in patients treated with cladribine for hairy cell leukemia.
    Mhawech-Fauceglia P; Oberholzer M; Aschenafi S; Baur A; Kurrer M; Von Rohr A; Hsu-Schmitz SF; Wagner B; Delacretaz F; Hurwitz N;
    Arch Pathol Lab Med; 2006 Mar; 130(3):374-7. PubMed ID: 16519567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cladribine in hairy cell leukemia.
    Belani R; Saven A
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders.
    Hoyer JD; Li CY; Yam LT; Hanson CA; Kurtin PJ
    Am J Clin Pathol; 1997 Sep; 108(3):308-15. PubMed ID: 9291460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of minimal residual disease in hairy cell leukemia after cladribine using immunohistochemistry and immunophenotyping.
    Tallman MS
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():65-8. PubMed ID: 21463116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyserythropoietic changes and sideroblastic anemia in patients with hairy cell leukemia before and after therapy with 2-chlorodeoxyadenosine.
    Zák P; Chrobák L; Podzimek K; Plísková L; Dedic K
    Neoplasma; 1998; 45(4):261-5. PubMed ID: 9890671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Jehn U; Bartl R; Dietzfelbinger H; Vehling-Kaiser U; Wolf-Hornung B; Hill W; Heinemann V
    Ann Hematol; 1999 Mar; 78(3):139-44. PubMed ID: 10211756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hairy cell leukemia. Diagnosis of bone marrow involvement in paraffin-embedded sections with monoclonal antibody DBA.44.
    Hounieu H; Chittal SM; al Saati T; de Mascarel A; Sabattini E; Pileri S; Falini B; Ralfkiaer E; Le Tourneau A; Selves J
    Am J Clin Pathol; 1992 Jul; 98(1):26-33. PubMed ID: 1615922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.